Perspective · 28 Oct 2022
CommentaryPublished 28 Jan 2022
Drug design with Artificial Intelligence
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Drug research relies heavily on Artificial Intelligence (AI). Artificial neural networks, such as deep neural networks and recurrent networks, are very important in this field. Numerous applications in property or activity predictions, such as physicochemical and ADMET characteristics, have lately emerged, demonstrating the technology's strength in Quantitative Structure-Property Relationships (QSPR) and Quantitative Structure-Activity Relationships (QSAR) (QSAR). De novo design uses artificial intelligence to guide the creation of new biologically active molecules that have the desired features. Artificial intelligence's strength in this subject is demonstrated by several cases. Combining synthesis planning and ease of synthesis is possible, and computer-aided drug discovery is predicted to become more common in the near future.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 27 Jul 2022
Decentralized Access Control Model Based on Artificial Intelligence and Blockchain Technology to Enable Secure Interoperability for Healthcare
Conference abstract · 12 Jul 2021
Artificial intelligence is changing healthcare - A digital marketing revolution.
Conference abstract · 28 Oct 2020
Transformative Leadership in the era of Artificial Intelligence in the Healthcare industry .
Conference abstract · 21 Aug 2018
Artificial intelligence supported leadership learning game for improving wellbeing, customer quality and business productivity
More from this journal
The newest in Health Economics & Outcome Research: Open Access.
Article · 26 Sep 2025
The future of drug licensing ai digital therapeutics and emerging trends
Article · 26 Sep 2025
Breaking down the fda approval process what every pharma innovator should know
Article · 26 Sep 2025
Inside a licensing agreement key clauses that shape pharma partnerships
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Economics & Outcome Research: Open Access
- SubjectBusiness & Management
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Lily Williams”

